CARA
CARA company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
2 articles
Price performance
Recent trading
Newsroom
Latest CARA coverage
Cara Therapeutics Continues to Climb (NASDAQ:CARA)
[ad_1] We suppose Cara Therapeutics (NASDAQ: CARA), a boutique “clinical stage” biotech/biopharma firm which develops novel compounds (together with hashish derived chemical compounds) for neuropathic ache is worthy of a detailed look. Cannabis regulation has been enjoyable each globally and within the United States and this influences our stance on CARA sto
What's Going On With Biotech Stocks 2018? Here's what we know…
Intro & History on ABBV (NYSE:ABBV) : In the biotech and medical marijuana arena, we think that ABBV AbbVie Inc. (NYSE ABBV) is an interesting and well known stock to keep an eye on. ABBV is a pharmaceutical development, discovery, manufacturing and sales firm based in Illinois near Chicago, and… We think Cara Therapeutics...